title: How to interpret intratreatment changes in plasma beta-2-microglobulin concentrations.
authors.affiliation: Department of Nephrology, University of Cologne, FRG.
authors.forename: T
authors.initials: T
authors.lastname: Marsen
authors.forename: R
authors.initials: R
authors.lastname: Hönig
authors.forename: S
authors.initials: S
authors.lastname: Schad
authors.forename: C
authors.initials: C
authors.lastname: Barth
authors.forename: M
authors.initials: M
authors.lastname: Pollok
authors.forename: C A
authors.initials: CA
authors.lastname: Baldamus
mesh_terms: D000180:Acrylic Resins; D001810:Blood Volume / Q000502:physiology; D001835:Body Weight; D015314:Dialysis Solutions; D005110:Extracellular Space / Q000502:physiology; D006440:Hemofiltration; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008567:Membranes, Artificial; D009994:Osmolar Concentration; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D012964:Sodium / Q000097:blood; D013997:Time Factors; D014508:Urea / Q000097:blood; D001613:beta 2-Microglobulin / Q000378:metabolism*
chemical_list: D000180:Acrylic Resins; D015314:Dialysis Solutions; D008567:Membranes, Artificial; D001613:beta 2-Microglobulin; C010504:polyacrylonitrile; D014508:Urea; D012964:Sodium